Tag: API and formulations
Glenmark reduces price of oral antiviral FabiFlu by 27 % to...
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely...